The Polio Vaccine Question Early 1954

You are advising the National Foundation for Infantile Paralysis, the charity funding much of America’s polio research.

Polio epidemics paralyse thousands of American children every summer. Jonas Salk has developed a vaccine made from inactivated (‘killed’) poliovirus that produced antibodies in early tests. The foundation must decide whether to back a nationwide field trial before the next polio season.

Known information

The United States recorded more than 57,000 polio cases in 1952.
Salk’s early tests showed antibody responses in vaccinated people, but no large trial has shown that the vaccine prevents paralysis.
Some leading virologists, including Albert Sabin, argue that a live, weakened-virus vaccine would give longer-lasting immunity.
Mass production brings a risk that live virus could survive the inactivation process in some batches.
A national trial would need hundreds of thousands of volunteers, parental consent and independent evaluation.

Reveal what happened (spoilers: decide first)

Fact

What actually happened

The foundation launched a nationwide field trial in 1954. (Launch the field trial this year)

The field trial began in April 1954 and eventually involved nearly two million American schoolchildren, known as ‘Polio Pioneers’. On 12 April 1955, evaluator Thomas Francis Jr. of the University of Michigan announced that the vaccine was safe and effective. Within weeks, some vaccine made by Cutter Laboratories was found to contain live virus and caused cases of polio, leading to stricter manufacturing controls.

Important

Possible consequences · Analysis and speculation, not fact

Waiting might have avoided some risks from early manufacturing but would likely have delayed protection during several more epidemic seasons. Estimating the number of cases involved is uncertain.

History does not reveal what would definitely have happened under the other choice. Many factors could have changed the outcome.

Context · Why it was decided this way

The trial was one of the largest medical experiments ever carried out, and parts of it used placebo injections and double-blind methods that influenced later clinical trials.

Sabin’s oral live-virus vaccine was tested in the late 1950s and licensed in the United States in the early 1960s. Both vaccines played roles in the dramatic fall in polio cases worldwide.